โรคพาเจทที่ปากช่องคลอด

ผู้แต่ง

  • Pakhanan Dankamak Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Kulisara Nanthamongkolkul Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Ingporn Jiamset Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Thiti Atjimakul Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.
  • Athithan Rattanaburi Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

DOI:

https://doi.org/10.31584/psumj.2024264403

คำสำคัญ:

โรคพาเจท, โรคพาเจทที่ปากช่องคลอด, เนื้องอกปากช่องคลอด, มะเร็งปากช่องคลอด, รอยโรคปากช่องคลอด, ปากช่องคลอด

บทคัดย่อ

โรคพาเจทที่ปากช่องคลอดเป็นโรคที่พบได้น้อยและวินิจฉัยได้ยาก อีกทั้งอาจเกี่ยวข้องกับมะเร็งชนิดอื่นๆ ได้ เช่น มะเร็งระบบทางเดินปัสสาวะ, มะเร็งระบบทางเดินอาหาร เป็นต้น จำเป็นต้องใช้การวินิจฉัยอย่างละเอียดรอบคอบ โดยการรักษาหลักของโรคพาเจทคือการผ่าตัด และมีการรักษาทางเลือกในกรณีที่ไม่สามารถผ่าตัดได้ เช่น การฉายแสง การใช้ยาทา และการให้เคมีบำบัดในโรคระยะแพร่กระจาย เนื่องจากโรคพาเจทนั้นมีการกลับเป็นซ้ำได้บ่อย ดังนั้นจึงต้องอาศัยการติดตามอย่างต่อเนื่อง ซึ่งบทความนี้ได้มีการรวบรวมและค้นคว้าข้อมูลเกี่ยวกับโรคพาเจทของปากช่องคลอด โดยมีเนื้อหาประกอบด้วย ที่มาของโรค ลักษณะโรคทางคลินิก ลักษณะรอยโรค การสืบค้นต่างๆ รวมไปถึงแนวทางการรักษาโรคพาเจทที่มีข้อมูลอยู่ในปัจจุบัน  

References

Paget J. On disease of the mammary areola preceding cancer of the mammary gland. St Bartholomew Hosp Res London 1874;10:87-9.

Dubreuilh W. Paget’s disease of the vulva. Br J Dermatol 1901;13:407-13.

Fardal RW, Kierland RR, Clagett OT, Woolner LB. Prognosis in cutaneous Paget’s disease. Postgrade Med 1964;36:584-93.

Van der Linden M, Meeuwis KA, Bulten J, Bosse T, van Poelgeest MIE, de Hullu JA. Paget disease of the vulva. Crit Rev Oncol Hematol 2016;101:60-74.

Kanitakis J. Mammary and extramammary Paget’s disease. J Eur Acad Dermatol Venereol 2007;21:581-90.

Willman JH, Golitz LE, Fitzpatrick JE. Vulvar clear cells of toker: precursors of extramammary Paget’s disease. Am J Dermatopathol 2005;27:185-8.

Van der Zwan JM, Siesling S, Blokx WA, Pierie JP, Capocaccia R. Invasive extramammary Paget’s disease and the risk for secondary tumours in Europe. Eur J Surg Oncol 2012;38:214-21.

Heng PS, Lu CL, Cheng CL, Lai FJ. Significant male predisposition in extramammary Paget disease: a nationwide population-based study in Taiwan. Br J Dermatol 2014;171:191-3.

De Magnis A, Checcucci V, Catalano C, Corazzesi A, Pieralli A, Taddei G, et al. Vulvar Paget disease: a large single-centre experience on clinical presentation, surgical treatment, and long-term outcomes. J Low Genit Tract Dis 2013;17:104-10.

Ishizuki S, Nakamura Y. Extramammary Paget’s disease: diagnosis, pathogenesis, and treatment with focus on recent developments. Curr Oncol 2021;28:2969-86.

Delport ES. Extramammary Paget’s disease of the vulva: an annotated review of the current literature. Australas J Dermatol 2013;54:9-21.

Berek JS, Hacker NF. Berek and Hacker’s Gynecologic Oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Willkins; 2021;p505-6.

American College of Obstetricians and Gynecologists. Diagnosis and management of vulvar skin disorders: ACOG practice bulletin summary, number 224. Obstet Gynecol 2020;136:222-5.

Bornstein J. Benign disorders of the vulva & vagina. In: Alan H. DeCherney ea, editor. Current diagnosis & treatment. Obstetrics & gynecology. 11th ed. New York: McGraw-Hill; 2013;620-45.

Wilkinson EJ, Brown HM. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002;33:549-54.

Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, et al. Evidence-based clinical practice guidelines for extramammary Paget disease. JAMA Oncol 2022;8:618-28.

Chiba H, Kazama T, Takenouchi T, Nomoto S, Yamada S, Tago O, et al. Two cases of vulval pigmented extramammary Paget’s disease: histochemical and immunohistochemical studies. Br J Dermatol 2000;142:1190-4.

Ito Y, Igawa S, Ohishi Y, Uehara J, Yamamoto AI, Iizuka H. Prognostic indicators in 35 patients with extramammary Paget’s disease. Dermatol Surg 2012;38:1938-44.

Zhao Y, Gong X, Li N, Zhu Q, Yu D, Jin X. Primary extramammary Paget’s disease: a clinicopathological study of 28 cases. Int J Clin Exp Pathol 2019;12:3426-32.

Kang Z, Zhang Q, Zhang Q, Li X, Hu T, Xu X, et al. Clinical and pathological characteristics of extramammary Paget’s disease: report of 246 Chinese male patients. Int J Clin Exp Pathol 2015;8:13233-40.

Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget’s disease. Br J Dermatol 2000;142:243-7.

Liao X, Liu X, Fan X, Lai J, Zhang D. Perianal Paget’s disease: a clinicopathological and immunohistochemical study of 13 cases. Diagn Pathol 2020;15:29.

Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentiation: its utility and limitations. World J Gastrointest Surg 2011;3:159-66.

Perrotto J, Abbott JJ, Ceilley RI, Ahmed I. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol 2010;32:137-43.

Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A. Interventions for the treatment of Paget’s disease of the vulva. Cochrane Database Syst Rev 2019;6:CD009245.

Chung PH, Leong JY, Voelzke BB. Surgical experience with genital and perineal extramammary Paget’s Disease. Urology 2019;128:90-5.

Mohs FE, Blanchard L. Microscopically controlled surgery for extramammary Paget’s disease. Arch Dermatol 1979;115:706-8.

Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 2004;51:767-73.

Chang MS, Mulvaney PM, Danesh MJ, Feltmate CM, Schmults CD. Modified peripheral and central Mohs micrographic surgery for improved margin control in extramammary Paget disease. JAAD Case Rep 2020;7:71-3.

Kato T, Fujimoto N, Fujii N, Tanaka T. Mapping biopsy with punch biopsies to determine surgical margin in extramammary Paget’s disease. J Dermatol 2013;40:968-72.

Nakamura Y, Ishitsuka Y, Nakamura Y, Xu X, Hori-Yamada E, Ito M, et al. Modified gluteal-fold flap for the reconstruction of vulvovaginal defects. Int J Dermatol 2010;49:1182-7.

Tsutsui K, Takahashi A, Muto Y, Mizuta H, Jinnai S, Nakama K, et al. Outcomes of lymph node dissection in the treatment of extramammary Paget’s disease: a single-institution study. J Dermatol 2020;47:512-7.

Burrows NP, Jones DH, Hudson PM, Pye RJ. Treatment of extramammary Paget’s disease by radiotherapy. Br J Dermatol 1995;132:970-2.

Hata M, Koike I, Wada H, Miyagi E, Kasuya T, Kaizu H, et al. Radiation therapy for extramammary Paget’s disease: treatment outcomes and prognostic factors. Ann Oncol 2014;25:291-7.

Hata M, Koike I, Wada H, Miyagi E, Kasuya T, Kaizu H, et al. Postoperative radiation therapy for extramammary Paget’s disease. Br J Dermatol 2015;172:1014-20.

Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999;21:1-14.

Marchitelli C, Peremateu MS, Sluga MC, Berasategui MT, Lopez DG, Wernicke A, et al. Treatment of primary vulvar Paget disease with 5% imiquimod cream. J Low Genit Tract Dis 2014;18:347-50.

Fontanelli R, Papadia A, Martinelli F, Lorusso D, Grijuela B, Merola M, et al. Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget’s disease. Gynecol Oncol 2013;130:90-4.

Hata M, Koike I, Wada H, Minagawa Y, Kasuya T, Matsui T, et al. Radiation therapy for lymph node metastasis from extramammary Paget’s disease. J Eur Acad Dermatol Venereol 2014;28:873-7.

Yoshino K, Fujisawa Y, Kiyohara Y, Kadono T, Murata Y, Uhara H, et al. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget’s disease. J Dermatol 2016;43:633-7.

Kato H, Watanabe S, Kariya K, Nakamura M, Morita A. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget’s disease. J Dermatol 2018;45:560-3.

Kato J, Hida T, Yamashita T, Kamiya S, Horimoto K, Sato S, et al. Successful TS-1 monotherapy as the second-line treatment for advanced extramammary Paget’s disease: a report of two cases. J Dermatol 2018;45:80-2.

Ichiyama T, Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Sakamoto A, et al. Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget’s disease: a case report and review of the literature. Mol Clin Oncol 2017;7:763-6.

Downloads

เผยแพร่แล้ว

2024-04-23

ฉบับ

บท

บทความปริทัศน์